© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 3, 190A-192,
February 2, 2000
© 2000 Oxford University Press
NEWS |
Bone Marrow Experts Are Still Debating the Value of Purging
High-dose chemotherapy and autologous bone marrow transplantation can be associated with patients living disease-free with some cancers for long periods of time. However, all too often the cancer returns. In patients with acute myeloid leukemia, for example, there is more than a 50% chance that the disease will return despite such treatment.
An alternative"purging"would clean the marrow of all cancer cells and, it is hoped, leave only hematopoietic stem cells and progenitor cells. These "rescued" hematopoietic stem cellsthe mother of all types of blood cellsand progenitor cellsstem cells that are committed to differentiating into a particular type of blood cellwould be put back into the body, giving birth to a new, cancer-free blood supply and immune system.
The strategy seems straightforwardin theory. Yet for many bone marrow transplant specialists, purging remains a controversial procedure. "Its an appealing concept,
Waiting for Proof
Positive Selection